| Product Code: ETC9974968 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Rapid Diagnostic Tests (RDT) Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Rapid Diagnostic Tests (RDT) Market - Industry Life Cycle |
3.4 United States (US) Rapid Diagnostic Tests (RDT) Market - Porter's Five Forces |
3.5 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.7 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 United States (US) Rapid Diagnostic Tests (RDT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for rapid and accurate diagnostic testing solutions |
4.2.2 Growing prevalence of infectious diseases and chronic conditions |
4.2.3 Technological advancements in rapid diagnostic tests |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of rapid diagnostic tests |
4.3.2 Limited reimbursement policies for rapid diagnostic tests |
4.3.3 Competition from traditional diagnostic methods |
5 United States (US) Rapid Diagnostic Tests (RDT) Market Trends |
6 United States (US) Rapid Diagnostic Tests (RDT) Market, By Types |
6.1 United States (US) Rapid Diagnostic Tests (RDT) Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Consumables and Kits, 2021- 2031F |
6.1.4 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Rapid Diagnostic Tests (RDT) Market, By Mode |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Professional Rapid Diagnostic Test Product, 2021- 2031F |
6.2.3 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Over-The-Counter [OTC] Rapid Diagnostic Test Product, 2021- 2031F |
6.3 United States (US) Rapid Diagnostic Tests (RDT) Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By PCR-Based, 2021- 2031F |
6.3.3 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Flow-Through Assays, 2021- 2031F |
6.3.4 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Lateral Flow Immunochromatographic Assays, 2021- 2031F |
6.3.5 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Agglutination Assay, 2021- 2031F |
6.3.6 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Microfluidics, 2021- 2031F |
6.3.7 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Substrate Technology, 2021- 2031F |
6.4 United States (US) Rapid Diagnostic Tests (RDT) Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.3 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 United States (US) Rapid Diagnostic Tests (RDT) Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Infectious Disease Testing, 2021- 2031F |
6.5.3 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Glucose Monitoring, 2021- 2031F |
6.5.4 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Cardiology Testing, 2021- 2031F |
6.5.5 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Oncology Testing, 2021- 2031F |
6.5.6 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Cardiometabolic Testing, 2021- 2031F |
6.5.7 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Drugs-of-Abuse Testing, 2021- 2031F |
6.5.8 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Toxicology Testing, 2021- 2031F |
6.5.9 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Toxicology Testing, 2021- 2031F |
6.5.10 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Rapid Diagnostic Tests (RDT) Market, By End users |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Hospital and Clinic, 2021- 2031F |
6.6.3 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Diagnostic Laboratory, 2021- 2031F |
6.6.4 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Home Care Setting, 2021- 2031F |
6.6.5 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Research and Academic Institutes, 2021- 2031F |
6.6.6 United States (US) Rapid Diagnostic Tests (RDT) Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Rapid Diagnostic Tests (RDT) Market Import-Export Trade Statistics |
7.1 United States (US) Rapid Diagnostic Tests (RDT) Market Export to Major Countries |
7.2 United States (US) Rapid Diagnostic Tests (RDT) Market Imports from Major Countries |
8 United States (US) Rapid Diagnostic Tests (RDT) Market Key Performance Indicators |
8.1 Adoption rate of rapid diagnostic tests by healthcare facilities |
8.2 Rate of new product launches and technological innovations in the market |
8.3 Market penetration of rapid diagnostic tests in different healthcare settings |
9 United States (US) Rapid Diagnostic Tests (RDT) Market - Opportunity Assessment |
9.1 United States (US) Rapid Diagnostic Tests (RDT) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Rapid Diagnostic Tests (RDT) Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.3 United States (US) Rapid Diagnostic Tests (RDT) Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 United States (US) Rapid Diagnostic Tests (RDT) Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 United States (US) Rapid Diagnostic Tests (RDT) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 United States (US) Rapid Diagnostic Tests (RDT) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 United States (US) Rapid Diagnostic Tests (RDT) Market - Competitive Landscape |
10.1 United States (US) Rapid Diagnostic Tests (RDT) Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Rapid Diagnostic Tests (RDT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here